The rapid expansion of the metabolic treatment market has created localized supply constraints for injectable delivery devices. Contract development and manufacturing organizations are rapidly converting existing production capacity to meet long-term volume commitments.
Capital Allocation Trends
Pharmaceutical logistics networks are investing heavily in cold-chain distribution infrastructure. Industry analysts project that fill-finish manufacturing capacity will remain constrained through the next six quarters despite aggressive facility expansions.